Cargando…

Abundant kif21b is associated with accelerated progression in neurodegenerative diseases

Kinesin family member 21b (kif21b) is one of the few multiple sclerosis (MS) risk genes with a presumed central nervous system function. Kif21b belongs to the kinesin family, proteins involved in intracellular transport of proteins and organelles. We hypothesised that kif21b is involved in the neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreft, Karim L, van Meurs, Marjan, Wierenga-Wolf, Annet F, Melief, Marie-Jose, van Strien, Miriam E, Hol, Elly M, Oostra, Ben A, Laman, Jon D, Hintzen, Rogier Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207309/
https://www.ncbi.nlm.nih.gov/pubmed/25274010
http://dx.doi.org/10.1186/s40478-014-0144-4
_version_ 1782340947506364416
author Kreft, Karim L
van Meurs, Marjan
Wierenga-Wolf, Annet F
Melief, Marie-Jose
van Strien, Miriam E
Hol, Elly M
Oostra, Ben A
Laman, Jon D
Hintzen, Rogier Q
author_facet Kreft, Karim L
van Meurs, Marjan
Wierenga-Wolf, Annet F
Melief, Marie-Jose
van Strien, Miriam E
Hol, Elly M
Oostra, Ben A
Laman, Jon D
Hintzen, Rogier Q
author_sort Kreft, Karim L
collection PubMed
description Kinesin family member 21b (kif21b) is one of the few multiple sclerosis (MS) risk genes with a presumed central nervous system function. Kif21b belongs to the kinesin family, proteins involved in intracellular transport of proteins and organelles. We hypothesised that kif21b is involved in the neurodegenerative component of MS and Alzheimer's (AD) disease. Post-mortem kinesin expression was assessed in 50 MS, 58 age and gender matched non-demented controls (NDC) and 50 AD. Kif21b expression was five-fold increased in AD compared to MS and NDC aged below 62 years (p = 8*10(-5)), three-fold between 62-72 years (p = 0.005) and not different above 72 years. No significant differences were observed between MS and NDC. In AD, kif21b expression was two-fold increased in Braak stage 6 (scoring for density of neurofibrillary tangles) compared with stage 5 (p = 0.003). In MS patients, kif21b correlated with the extent of grey matter demyelination (Spearman's rho = 0.31, p = 0.03). Abundant kif21b, defined as expression above the median, was associated with a two-fold accelerated development of the Kurtzke Expanded Disability Status Scale (EDSS) 6.0 (median time in low kif21b group 16 years vs. high kif21b 7.5 years, log-rank test p = 0.04) in MS. Given the genetic association of kif21b with MS, the results were stratified according to rs12122721[A] single nucleotide polymorphism (SNP). No association was found between kif21b expression or the time to EDSS 6 in kif21b risk SNP carriers compared to non-risk carriers. Kif21b was expressed in astrocytes in addition to neurons. Upon astrocyte activation, kif21b increased nine-fold. Abundant kif21b expression is associated with severe MS and AD pathology and with accelerated neurodegeneration independent of the kif21b risk SNP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-014-0144-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4207309
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42073092014-10-28 Abundant kif21b is associated with accelerated progression in neurodegenerative diseases Kreft, Karim L van Meurs, Marjan Wierenga-Wolf, Annet F Melief, Marie-Jose van Strien, Miriam E Hol, Elly M Oostra, Ben A Laman, Jon D Hintzen, Rogier Q Acta Neuropathol Commun Research Kinesin family member 21b (kif21b) is one of the few multiple sclerosis (MS) risk genes with a presumed central nervous system function. Kif21b belongs to the kinesin family, proteins involved in intracellular transport of proteins and organelles. We hypothesised that kif21b is involved in the neurodegenerative component of MS and Alzheimer's (AD) disease. Post-mortem kinesin expression was assessed in 50 MS, 58 age and gender matched non-demented controls (NDC) and 50 AD. Kif21b expression was five-fold increased in AD compared to MS and NDC aged below 62 years (p = 8*10(-5)), three-fold between 62-72 years (p = 0.005) and not different above 72 years. No significant differences were observed between MS and NDC. In AD, kif21b expression was two-fold increased in Braak stage 6 (scoring for density of neurofibrillary tangles) compared with stage 5 (p = 0.003). In MS patients, kif21b correlated with the extent of grey matter demyelination (Spearman's rho = 0.31, p = 0.03). Abundant kif21b, defined as expression above the median, was associated with a two-fold accelerated development of the Kurtzke Expanded Disability Status Scale (EDSS) 6.0 (median time in low kif21b group 16 years vs. high kif21b 7.5 years, log-rank test p = 0.04) in MS. Given the genetic association of kif21b with MS, the results were stratified according to rs12122721[A] single nucleotide polymorphism (SNP). No association was found between kif21b expression or the time to EDSS 6 in kif21b risk SNP carriers compared to non-risk carriers. Kif21b was expressed in astrocytes in addition to neurons. Upon astrocyte activation, kif21b increased nine-fold. Abundant kif21b expression is associated with severe MS and AD pathology and with accelerated neurodegeneration independent of the kif21b risk SNP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-014-0144-4) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-03 /pmc/articles/PMC4207309/ /pubmed/25274010 http://dx.doi.org/10.1186/s40478-014-0144-4 Text en © Kreft et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kreft, Karim L
van Meurs, Marjan
Wierenga-Wolf, Annet F
Melief, Marie-Jose
van Strien, Miriam E
Hol, Elly M
Oostra, Ben A
Laman, Jon D
Hintzen, Rogier Q
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
title Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
title_full Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
title_fullStr Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
title_full_unstemmed Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
title_short Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
title_sort abundant kif21b is associated with accelerated progression in neurodegenerative diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207309/
https://www.ncbi.nlm.nih.gov/pubmed/25274010
http://dx.doi.org/10.1186/s40478-014-0144-4
work_keys_str_mv AT kreftkariml abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT vanmeursmarjan abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT wierengawolfannetf abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT meliefmariejose abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT vanstrienmiriame abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT holellym abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT oostrabena abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT lamanjond abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases
AT hintzenrogierq abundantkif21bisassociatedwithacceleratedprogressioninneurodegenerativediseases